Research use only, not for human consumption. Email [email protected]
← Research status explorer
Peak / Growth axis

Ipamorelin

Current research status Human Research
Human pharmacology/clinical research
Preclinical
Human Research

Overview

Ipamorelin is a selective ghrelin-receptor agonist (growth hormone secretagogue) studied in human pharmacology trials, including in combination with GHRH analogues, for its growth-hormone-releasing effects with comparatively little impact on cortisol or prolactin. It has not completed a conventional Phase 1–3 program leading to drug approval.

Last reviewed: September 2026